Table 3.
Characteristics and ICU admission due to COVID-19.
| ICU | Univariate | MultivariateBinary Logistic Regression | |||||
|---|---|---|---|---|---|---|---|
| Yes (%) | No (%) | p-Value | OR with 95% CI | RR with 95% CI | p-Value | aOR with 95% CI | |
| Sex (M/F) | 36/17 | 117/85 | 0.186 * | 1.54 (0.81–2.92) | 1.41 (0.84–2.37) | 0.305 | 1.45 (0.72–2.93) |
| Age (median, IQR) | 66.2 (17) | 60.4 (24) | 0.030 ± | - | - | 0.649 | 1.01 (0.98–1.04) |
| Atrial Fibrillation | 21 (36.9) | 61 (30.2) | 0.191* | 1.52 (0.81–2.84) | 1.39 (0.85–2.25) | 0.966 | 0.98 (0.43–2.23) |
| Respiratory Disease | 11 (20.8) | 21 (10.4) | 0.043 * | 2.26 (1.01–5.04) | 1.83 (1.05–3.17) | 0.205 | 1.80 (0.73–4.46) |
| Coronary Disease | 16 (30.2) | 34 (16.8) | 0.029 * | 2.14 (1.07–4.27) | 1.77 (1.08–2.92) | 0.393 | 1.48 (0.61–3.59) |
| Diabetes | 10 (18.9) | 43 (21.3) | 0.699 * | 0.86 (0.40–1.85) | 0.87 (0.48–1.64) | 0.098 | 0.49 (0.21–1.14) |
| Neoplasia | 4 (7.5) | 25 (12.4) | 0.466 † | 0.58 (0.19–1.74) | 0.64 (0.25–1.63) | 0.102 | 0.37 (0.11–1.22) |
| Hyperlipidemia | 22 (41.5) | 91 (45.0) | 0.644 * | 0.87 (0.47–1.60) | 0.89 (0.55–1.45) | 0.033 | 0.44 (0.21–0.94) |
| Hypertension | 42 (79.2) | 100 (49.5) | <0.001 * | 3.90 (1.90–7.99) | 3.04 (1.64–5.63) | 0.001 | 5.12 (2.04–12.87) |
| β-Thalassemia Heterozygotes | 11 (20.8) | 34 (16.8) | 0.505 * | 1.29 (0.61–2.77) | 1.22 (0.68–2.18) | 0.508 | 1.33 (0.57–3.06) |
* Chi-square test, ± Mann–Whitney test, † Fisher’s exact test; Bold is for the statistically significant results (p-value < 0.05).